News Release: Research , School of Medicine , Woodruff Health Sciences

Mar. 16,  2010

Fourth Celebration of Technology and Innovation Recognizes Tech Transfer Success

Fourth Annual Celebration of Technology and Innovation, Program and Reception

Thursday, March 25, 4:30 to 7:30 p.m.

Emory Conference Center, Silver Bell Pavilion, 1615 Clifton Rd., Atlanta, GA 30322

Joseph Allen, President, Joseph Allen and Associates: "30 Years of U.S. Technology Policy in 30 Minutes (Along with Thoughts on the Future)"

Joseph Allen is a 30-year veteran of national efforts to foster public/private sector commercialization partnerships. He served as a professional staff member on the U.S. Senate Judiciary Committee with former Senator Birch Bayh (D-In) and was the key staffer securing passage of the Bayh-Dole Act, opening up collaborations between research universities and U.S. industry. In 1999 the Association of University Technology Managers awarded Allen the prestigious Bayh-Dole Award for this achievement. He created the consulting firm Joseph Allen and Associates in 2008, and his clients include the Association of University Technology Managers and the Biotechnology Industry Organization.

Emory Annual Celebration Winners 2009:

Start-up of the Year:
NeurOp Corporation Raymond Dingledine, PhD, and Stephen Traynelis, PhD, Department of Pharmacology, Emory School of Medicine

Deal of the Year:
Alimera Sciences, Inc., licensing agreement Jack Arbiser, MD, PhD, Department of Dermatology, Emory School of Medicine

Innovation of the Year:
Integrated Imaging and Spectroscopy Systems for Image-Guided Surgery Shuming Nie, PhD, Wallace H. Coulter Department of Biomedical Engineering, Georgia Tech and Emory University; Winship Cancer Institute, Emory University

Significant Event:
BHR Pharma, LLC, Investigational New Drug (IND) submission, and acceptance of Orphan Drug Status Donald Stein, PhD; Arthur Kellermann, MD, PhD; David Wright, MD; Stuart Hoffman, PhD; Douglas Lowery-North, MD, Department of Emergency Medicine, Emory School of Medicine

For more information about the winners, download this flyer (PDF).

404-727-2211 or

Technology Transfer at Emory

Emory University's technology transfer program has one of the most robust product pipelines of any university in the country, with one of the nation's leading programs for guiding technology developed in the laboratory through the patenting and licensing process to the marketplace and into the hands of consumers and patients. Since the 1990s, Emory has received more than $775 million in licensing revenues from drugs, diagnostics, devices and consumer products.

The technology transfer program has resulted in 27 licensed therapeutic products, medical devices, and diagnostics already in the marketplace and 12 more in human clinical trials. Emory has launched 47 start-up companies resulting from licensed discoveries. The most widely used drugs for HIV/AIDS, diagnostic tests for genetic disorders, drugs for cancer, a technology to improve angioplasty, and imaging software for diagnosing cardiovascular disease are among the many Emory discoveries now commercially available for patients and physicians.

For more information, see


The Robert W. Woodruff Health Sciences Center of Emory University is an academic health science and service center focused on missions of teaching, research, health care and public service.

Learn more about Emory’s health sciences:
Twitter: @emoryhealthsci

News Release Tools

  • Print

News Releases

The news release you are currently viewing is part of an archive of Emory health sciences press releases, dating Sept. 2008 - Dec. 2011.

To View Current Releases

Emory News Center

Emory News Center

To View News Archives

News Archives

News Archives